Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
87M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
36.6M
-
Shares change
-
+15M
-
Total reported value, excl. options
-
$904M
-
Value change
-
+$375M
-
Put/Call ratio
-
0.71
-
Number of buys
-
84
-
Number of sells
-
-22
-
Price
-
$24.68
Significant Holders of Immunome Inc. - COMMON STOCK (IMNM) as of Q1 2024
117 filings reported holding IMNM - Immunome Inc. - COMMON STOCK as of Q1 2024.
Immunome Inc. - COMMON STOCK (IMNM) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.6M shares
of 87M outstanding shares and own 42.06% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (4.89M shares), FMR LLC (4.53M shares), EcoR1 Capital, LLC (3.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.25M shares), VANGUARD GROUP INC (2.02M shares), Point72 Asset Management, L.P. (1.64M shares), JANUS HENDERSON GROUP PLC (1.54M shares), T. Rowe Price Investment Management, Inc. (1.52M shares), Woodline Partners LP (1.32M shares), and Avidity Partners Management LP (874K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.